Proton Shuttles and Phosphatase Activity in Soluble Epoxide Hydrolase

Por De Vivo, Marco, Ensing, Bernd, Peraro, Matteo Dal, Gomez, German A., Christianson, David W., Klein, Michael L.
Publicado em 2007

Inhibition of HIV Virus by Neutralizing Vhh Attached to Dual Functional Liposomes Encapsulating Dapivirine

Por Wang, Scarlet Xiaoyan, Michiels, Johan, Ariën, Kevin K., New, Roger, Vanham, Guido, Roitt, Ivan
Publicado no Nanoscale Res Lett (2016)

Psychosocial Characteristics of New York City HIV-Infected Women Before and After the Advent of HAART

Por Siegel, Karolynn, Karus, Daniel, Dean, Laura
Publicado em 2004

Use of HAART Among Young People Living With HIV

Por Comulada, W. Scott, Swendeman, Dallas T., Rotheram-Borus, Mary Jane, Mattes, Kathy M., Weiss, Robert E.
Publicado em 2003

Factors associated with 10 years of continuous viral load suppression on HAART

Por Bello, Kathryn J., Mesner, Octavio, O’Bryan, Thomas A., Won, Seung Hyun, Lalani, Tahaniyat, Ganesan, Anuradha, Agan, Brian K., Okulicz, Jason F.
Publicado no BMC Infect Dis (2016)

Limits on Replenishment of the Resting CD4(+) T Cell Reservoir for HIV in Patients on HAART

Por Sedaghat, Ahmad R, Siliciano, Janet D, Brennan, Timothy P, Wilke, Claus O, Siliciano, Robert F
Publicado em 2007

Malignancies in human immunodeficiency virus infected patients in India: Initial experience in the HAART era

Por Sharma, Surendra K., Soneja, Manish, Ranjan, Sanjay
Publicado no Indian J Med Res (2015)

Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy (HAART)

Por Viswanathan, Shilpa, Justice, Amy C., Alexander, G. Caleb, Brown, Todd T., Gandhi, Neel R., McNicholl, Ian R., Rimland, David, Rodriguez-Barradas, Maria C., Jacobson, Lisa P.
Publicado no J Acquir Immune Defic Syndr (2015)

HIV-related Pneumocystis carinii Pneumonia in Older Patients Hospitalized in the Early HAART Era

Por Kim, Benjamin, Lyons, Thomas M, Parada, Jorge P, Uphold, Constance R, Yarnold, Paul R, Hounshell, Jennie B, Sipler, Alison M, Goetz, Matthew B, DeHovitz, Jack A, Weinstein, Robert A, Campo, Rafael E, Bennett, Charles L
Publicado em 2001

Impact of Timing of Starting Treatment Following Infection with Application to Initiating HAART in HIV-Positive Patients

Por Lok, Judith J., DeGruttola, Victor
Publicado em 2012

Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.

Por Stephane Champiat, Rui André Saraiva Raposo, Nicholas J Maness, John L Lehman, Sean E Purtell, Aaron M Hasenkrug, Jacob C Miller, Hansi Dean, Wayne C Koff, Marisa Ailin Hong, Jeffrey N Martin, Steven G Deeks, Gerald E Spotts, Christopher D Pilcher, Fredrick M Hecht, Esper G Kallas, Keith E Garrison, Douglas F Nixon
Publicado em 2012-01-01

Influence of HAART on Alternative Reading Frame Immune Responses over the Course of HIV-1 Infection

Por Champiat, Stephane, Raposo, Rui André Saraiva, Maness, Nicholas J., Lehman, John L., Purtell, Sean E., Hasenkrug, Aaron M., Miller, Jacob C., Dean, Hansi, Koff, Wayne C., Hong, Marisa Ailin, Martin, Jeffrey N., Deeks, Steven G., Spotts, Gerald E., Pilcher, Christopher D., Hecht, Fredrick M., Kallas, Esper G., Garrison, Keith E., Nixon, Douglas F.
Publicado em 2012

Survival of AIDS patients in Sao Paulo-Brazil in the pre- and post-HAART eras: a cohort study

Por Tancredi, Mariza Vono, Waldman, Eliseu Alves
Publicado no BMC Infect Dis (2014)

Causes of Death among People Living with AIDS in the Pre- and Post-HAART Eras in the City of São Paulo, Brazil

Por Domingues, Carmen-Silvia Bruniera, Waldman, Eliseu Alves
Publicado no PLoS One (2014)

Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada.

Por Viviane D Lima, Robert S Hogg, Julio S G Montaner
Publicado em 2010-06-01

Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada

Por Lima, Viviane D., Hogg, Robert S., Montaner, Julio S. G.
Publicado em 2010

Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAART.

Por Steven Sanche, Thibault Mesplède, Nancy L Sheehan, Jun Li, Fahima Nekka
Publicado em 2018-01-01

Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAART

Por Sanche, Steven, Mesplède, Thibault, Sheehan, Nancy L., Li, Jun, Nekka, Fahima
Publicado no PLoS One (2018)

The effect of standard dose multivitamin supplementation on disease progression in HIV-infected adults initiating HAART: a randomized double blind placebo-controlled trial in Uganda

Por Guwatudde, David, Wang, Molin, Ezeamama, Amara E., Bagenda, Danstan, Kyeyune, Rachel, Wamani, Henry, Manabe, Yukari C., Fawzi, Wafaie W.
Publicado no BMC Infect Dis (2015)

Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial

Por Amogne, Wondwossen, Aderaye, Getachew, Habtewold, Abiy, Yimer, Getnet, Makonnen, Eyasu, Worku, Alemayhu, Sonnerborg, Anders, Aklillu, Eleni, Lindquist, Lars
Publicado no PLoS One (2015)